LONDON (Reuters) - A popular baldness drug taken by more than 4 million men worldwide can mask an important marker used in screening tests to detect prostate cancer, scientists said on Monday.>>> Discuss This Story
LONDON (Reuters) - A popular baldness drug taken by more than 4 million men worldwide can mask an important marker used in screening tests to detect prostate cancer, scientists said on Monday.>>> Discuss This Story